The Journal of Pediatrics
Volume 153, Issue 2 , Pages 157-158 , August 2008

In Defense of Empiric Acyclovir Therapy in Certain Neonates

  • Sarah S. Long, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Sarah S. Long, MD, St. Christopher's Hospital for Children, Section of Infectious Diseases, Erie Avenue at Front Street, Philadelphia, PA 19134-1095.

References 

  1. Caviness AC, Demmler GJ, Almendarez Y, et al. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr. 2008;153:164–169
  2. Kimberlin DW. When should you initiate acyclovir therapy in a neonate?. J Pediatr. 2008;153:155–156
  3. Verboon-Maciolek MA, Nijhuis M, van Loon AM, et al. Diagnosis of enterovirus infection in the first 2 months of life by real-time polymerase chain reaction. Clin Infect Dis. 2003;37:1–6
  4. Rittichier KR, Bryan PA, Bassett KE, et al. Diagnosis and outcomes of enterovirus infections in young infants. Pediatr Infect Dis J. 2005;24:546–550
  5. Petwijit T, Desudchit T, Punnahitanonda S, et al. A prospective study of enterovirus infection in Thai infants presenting as sepsis. Asian Biomed. 2007;1:59–65

PII: S0022-3476(08)00381-8

doi: 10.1016/j.jpeds.2008.04.071

The Journal of Pediatrics
Volume 153, Issue 2 , Pages 157-158 , August 2008